Cargando…
Effects of microbiota on anticancer drugs: Current knowledge and potential applications
Over the last decade, mounting evidence has revealed the key roles of gut microbiota in modulating the efficacy and toxicity of anticancer drugs, via mechanisms such as immunomodulation and microbial enzymatic degradation. As such, human microbiota presents as an exciting prospect for developing bio...
Autores principales: | Huang, Jiayuan, Liu, Wenting, Kang, Wanying, He, Yulong, Yang, Ruifu, Mou, Xiangyu, Zhao, Wenjing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358415/ https://www.ncbi.nlm.nih.gov/pubmed/35933808 http://dx.doi.org/10.1016/j.ebiom.2022.104197 |
Ejemplares similares
-
MADET: a Manually Curated Knowledge Base for Microbiomic Effects on Efficacy and Toxicity of Anticancer Treatments
por: Zhang, Jie, et al.
Publicado: (2022) -
Metagenomic and metabolomic analyses reveal synergistic effects of fecal microbiota transplantation and anti-PD-1 therapy on treating colorectal cancer
por: Huang, Jiayuan, et al.
Publicado: (2022) -
Emerging Applications of Bacteriocins as Antimicrobials, Anticancer Drugs, and Modulators of The Gastrointestinal Microbiota
por: CESA-LUNA, CATHERINE, et al.
Publicado: (2021) -
Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies
por: Panebianco, Concetta, et al.
Publicado: (2018) -
Functional ligands for improving anticancer drug therapy: current status and applications to drug delivery systems
por: Bajracharya, Rajiv, et al.
Publicado: (2022)